BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32039436)

  • 1. Treatment of reactive arthritis with biological agents: a review.
    Zeng H; Luo B; Zhang Y; Xie Z; Ye Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32039436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactive arthritis - a disease almost forgotten?].
    Märker-Hermann E
    Dtsch Med Wochenschr; 2020 Dec; 145(24):1786-1790. PubMed ID: 33254255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Tanaka T; Kuwahara Y; Shima Y; Hirano T; Kawai M; Ogawa M; Arimitsu J; Hagihara K; Narazaki M; Ogata A; Kawase I; Kishimoto T
    Arthritis Rheum; 2009 Dec; 61(12):1762-4. PubMed ID: 19950316
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of reactive arthritis.
    Palazzi C; Olivieri I; D'Amico E; Pennese E; Petricca A
    Expert Opin Pharmacother; 2004 Jan; 5(1):61-70. PubMed ID: 14680436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive arthritis.
    Kwiatkowska B; Filipowicz-Sosnowska A
    Pol Arch Med Wewn; 2009; 119(1-2):60-5. PubMed ID: 19341180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secukinumab therapy in reactive arthritis: Report of two cases.
    Padhan P; Maikap D
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):22-24. PubMed ID: 34508266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy.
    Jensen AK; Chatzidionysiou K; Torp CK; Sørensen AS; Tenstad HB; Schäfer VS; Kostine M; Jacobsen S; Leipe J; Kragstrup TW
    Biomed Pharmacother; 2022 Apr; 148():112687. PubMed ID: 35228067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving patterns of reactive arthritis.
    Hayes KM; Hayes RJP; Turk MA; Pope JE
    Clin Rheumatol; 2019 Aug; 38(8):2083-2088. PubMed ID: 30919146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection and musculoskeletal conditions: Reactive arthritis.
    Rihl M; Klos A; Köhler L; Kuipers JG
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1119-37. PubMed ID: 17127200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive arthritis: developments and challenges in diagnosis and treatment.
    Morris D; Inman RD
    Curr Rheumatol Rep; 2012 Oct; 14(5):390-4. PubMed ID: 22821199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis.
    Alanärä T; Aittomäki S; Kuuliala K; Kuuliala A; Siitonen S; Leirisalo-Repo M; Repo H
    Scand J Rheumatol; 2012 Aug; 41(4):267-74. PubMed ID: 22651550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of reactive arthritis with infliximab.
    Oili KS; Niinisalo H; Korpilähde T; Virolainen J
    Scand J Rheumatol; 2003; 32(2):122-4. PubMed ID: 12737333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and Safety of Tumor Necrosis Factor Inhibitors in Reactive Arthritis: A Nationwide Experience from Iceland.
    Thorsteinsson B; Geirsson AJ; Krogh NS; Gudbjornsson B;
    J Rheumatol; 2020 Oct; 47(10):1575-1581. PubMed ID: 32007931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies toward rheumatoid arthritis therapy; the old and the new.
    Abbasi M; Mousavi MJ; Jamalzehi S; Alimohammadi R; Bezvan MH; Mohammadi H; Aslani S
    J Cell Physiol; 2019 Jul; 234(7):10018-10031. PubMed ID: 30536757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive Arthritis: Treatment Challenges and Future Perspectives.
    Wendling D; Prati C; Chouk M; Verhoeven F
    Curr Rheumatol Rep; 2020 May; 22(7):29. PubMed ID: 32458153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future use of biologic agents alone and in combination for the treatment of rheumatoid arthritis.
    Strand V
    Z Rheumatol; 1998 Feb; 57(1):41-5. PubMed ID: 9566107
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of reactive arthritis.
    Pennisi M; Perdue J; Roulston T; Nicholas J; Schmidt E; Rolfs J
    JAAPA; 2019 Jul; 32(7):25-28. PubMed ID: 31169570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive arthritis: newer developments.
    Flores D; Marquez J; Garza M; Espinoza LR
    Rheum Dis Clin North Am; 2003 Feb; 29(1):37-59, vi. PubMed ID: 12635499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of bifidum-containing preparations in enterogenous reactive arthritis].
    Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI
    Ter Arkh; 1991; 63(5):33-6. PubMed ID: 1887411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.